These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 3411305)

  • 1. [The Ehlers-Danlos and Marfan syndromes in young children].
    De Paepe A; Van den Bossche H; Mortier G; Matton M
    J Genet Hum; 1988 Jun; 36(3):247-53. PubMed ID: 3411305
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Vascular Ehlers-Danlos syndromes--biochemical and molecular-genetic investigations].
    Lund AM
    Ugeskr Laeger; 2006 Feb; 168(9):915-20. PubMed ID: 16513057
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ehlers-Danlos syndromes and Marfan syndrome.
    Callewaert B; Malfait F; Loeys B; De Paepe A
    Best Pract Res Clin Rheumatol; 2008 Mar; 22(1):165-89. PubMed ID: 18328988
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Abnormality of dermal collagen fibrils in Ehlers Danlos syndrome. Anticipation of the abnormality for the inherited hypermobile disorders.
    Kobayasi T
    Eur J Dermatol; 2004; 14(4):221-9. PubMed ID: 15319154
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phenotypic overlap of Ehlers-Danlos syndrome types IV and VIII.
    Hartsfield JK; Kousseff BG
    Am J Med Genet; 1990 Dec; 37(4):465-70. PubMed ID: 2260589
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enzyme-linked immunoassay and electrophoretic separation of collagens secreted by cultured skin fibroblasts of patients with Ehlers-Danlos and Marfan syndromes.
    Borisova NV; Safronova EE; Krasnopol'skaya KD; Blinnikova OE; Polyudov SA
    Biomed Sci; 1991; 2(5):523-9. PubMed ID: 1840842
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular genetics of Marfan syndrome and Ehlers-Danlos type IV.
    Milewicz DM
    Curr Opin Cardiol; 1998 May; 13(3):198-204. PubMed ID: 9649943
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Type IV Ehlers-Danlos syndrome with aspirin sensitivity. A family study.
    Grenko RT; Burns SL; Golden EA; Byers PH; Bovill EG
    Arch Pathol Lab Med; 1993 Oct; 117(10):989-92. PubMed ID: 8215841
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Large kindred with Ehlers-Danlos syndrome type IV due to a point mutation (G571S) in the COL3A1 gene of type III procollagen: low risk of pregnancy complications and unexpected longevity in some affected relatives.
    Gilchrist D; Schwarze U; Shields K; MacLaren L; Bridge PJ; Byers PH
    Am J Med Genet; 1999 Feb; 82(4):305-11. PubMed ID: 10051163
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The molecular basis of classic Ehlers-Danlos syndrome: a comprehensive study of biochemical and molecular findings in 48 unrelated patients.
    Malfait F; Coucke P; Symoens S; Loeys B; Nuytinck L; De Paepe A
    Hum Mutat; 2005 Jan; 25(1):28-37. PubMed ID: 15580559
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Periodontal Ehlers-Danlos syndrome associated with type III and I collagen deficiencies.
    Mataix J; Bañuls J; Muñoz C; Bermejo A; Climent JM
    Br J Dermatol; 2008 Apr; 158(4):825-30. PubMed ID: 18284404
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genetic linkage to the collagen alpha 1 (V) gene (COL5A1) in two British Ehlers-Danlos syndrome families with variable type I and II phenotypes.
    Burrows NP; Nicholls AC; Yates JR; Richards AJ; Pope FM
    Clin Exp Dermatol; 1997 Jul; 22(4):174-6. PubMed ID: 9499606
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Single-strand conformation polymorphism (SSCP) analysis of the COL3A1 gene detects a mutation that results in the substitution of glycine 1009 to valine and causes severe Ehlers-Danlos syndrome type IV.
    Nuytinck L; De Paepe A; Renard JP; Adriaens F; Leroy J
    Hum Mutat; 1994; 3(3):268-74. PubMed ID: 8019562
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Simultaneous occurrence of Ehlers-Danlos syndrome and Marfan's syndrome].
    Fazekas A
    Orv Hetil; 1976 Jan; 117(3):154-8. PubMed ID: 1246406
    [No Abstract]   [Full Text] [Related]  

  • 15. [Type IV Ehlers-Danlos syndrome of acrogeria type].
    Boullie MC; Venencie PY; Thomine E; Ogier H; Puissant A; Lauret P
    Ann Dermatol Venereol; 1986; 113(11):1077-85. PubMed ID: 3813397
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ehlers-Danlos syndrome IV due to a novel defect in type III procollagen.
    Pyeritz RE; Stolle CA; Parfrey NA; Myers JC
    Am J Med Genet; 1984 Nov; 19(3):607-22. PubMed ID: 6507506
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Ehlers-Danlos syndrome IV: phenotype variation].
    Engels CH; van Dongen PW; Boers GH; Steijlen PM; Hamel BC
    Ned Tijdschr Geneeskd; 1997 Feb; 141(6):296-8. PubMed ID: 9148166
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Ehlers-Danlos syndromes.
    Yeowell HN; Pinnell SR
    Semin Dermatol; 1993 Sep; 12(3):229-40. PubMed ID: 8217561
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Ehlers-Danlos syndrome type I. Ultrastructural study].
    Paradisi M; Giubilei L; Canzona F; Angelo C; Onetti Muda A; Puddu P
    Minerva Pediatr; 1997 May; 49(5):215-9. PubMed ID: 9340484
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Homozygous Gly530Ser substitution in COL5A1 causes mild classical Ehlers-Danlos syndrome.
    Giunta C; Nuytinck L; Raghunath M; Hausser I; De Paepe A; Steinmann B
    Am J Med Genet; 2002 May; 109(4):284-90. PubMed ID: 11992482
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.